Medisca and EUROAPI form a strategic partnership to strengthen API access for pharmaceutical compounding.

October 7, 2026

EUROAPI has entered into a distribution partnership with Medisca, a leader in personalized medicine and pharmaceutical supply chain solutions to support access to selected EUROAPI-manufactured active pharmaceutical ingredients for the North American compounding market.

Drawing EUROAPI’s European manufacturing and technical capabilities and Medisca’s expertise in pharmaceutical compounding, the partnership will help facilitate access to selected APIs in North America and strengthen EUROAPI’s presence in this specialized market.

Beyond expanding access to selected APIs, the partnership creates an opportunity for future growth through customer-focused initiatives, portfolio expansion and collaboration in strategic areas.

“Medisca’s depth of expertise in pharmaceutical compounding and its close understanding of the market make it a strong strategic partner for EUROAPI,” said Frédéric Robert, Chief Commercial Officer at EUROAPI. “This relationship creates new opportunities to broaden access to our APIs, expand our reach in the compounding market and develop our collaboration. We see significant potential to grow together over the long term.”